Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Propagermanium
Drug ID BADD_D01858
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01626
MeSH ID C066750
PubChem ID 83030
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 1Q2P9TO9Q7
Synonyms propagermanium | bis(carboxyethyl)germanium sesquioxide | DCEFSQD | carboxyethylgermanium sesquioxide | dicarboxyethenylgermanium sesquioxide | repagermanium | proxigermanium | dihydrogen bis(2-carboxylatoethyl)trioxodigermanate(2-) | bis(2-carboxyethyl)germanium sesquioxide | beta carboxyethylgermanium sesquioxide | 3,3'-(1,3-dioxo-1,3-digermoxanediyl)dipropionic acid | Ge 132 | Germanium-132 | Ge-132 | Arlamol Gel | 3-oxygermylpropionic acid polymer | SK 818 | SK-818
Chemical Information
Molecular Formula C6H10Ge2O7
CAS Registry Number 12758-40-6
SMILES C(C[Ge](=O)O[Ge](=O)CCC(=O)O)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Glomerulonephritis20.05.01.001; 10.02.01.006--Not Available
Haemorrhage intracranial24.07.04.003; 17.08.01.008--
Hallucination19.10.04.003--
Headache17.14.01.001--
Hepatitis09.01.07.004--Not Available
Hepatitis B11.05.28.003; 09.01.09.003--
Hepatitis C11.05.28.004; 09.01.09.005--Not Available
Hepatitis viral11.05.04.011; 09.01.09.007--
Herpes simplex23.11.05.004; 11.05.02.001--Not Available
Herpes virus infection11.05.02.008--Not Available
Herpes zoster23.11.05.005; 17.09.03.026; 11.05.02.003--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperplasia08.03.04.008--Not Available
Hyperreflexia17.02.01.002--Not Available
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hyperventilation22.02.01.006; 19.01.02.004--Not Available
Hypervolaemia02.05.04.019; 14.05.06.003--Not Available
Hypotension24.06.03.002--
Hypotonia17.05.02.002; 15.05.04.008--Not Available
Hypoxia22.02.02.003--
Intestinal infarction07.15.02.006; 24.04.08.008--Not Available
Keratoacanthoma23.08.02.007; 16.03.02.007--Not Available
Laryngospasm22.04.02.002--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Leukaemia16.01.03.001; 01.10.03.001--
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001--Not Available
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.005--Not Available
Lymphadenopathy01.09.01.002--Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 7 Pages